ANXA3 and Huntington disease: When we plotted the DeepSAGE gene expression levels of these three genes across the controls, the presymptomatic carriers and the different HD TFC-based disease stages, we could confirm that for ANXA3 and AQP9 there was an increase in gene expression even in the presymptomatic stage.